|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/505 | |
| A61K 31/497 | |||
| C07D 239/56 | |||
| C07D 239/54 | |||
| C07D 417/08 |
| (11) | Patento numeris | 2685827 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12760812.3 |
| Europos patento paraiškos padavimo data | 2012-03-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/029376 |
| Data | 2012-03-16 |
| (87) | Numeris | WO 2012/129074 |
| Data | 2012-09-27 |
| (30) | Numeris | Data | Šalis |
| 201161454289 P | 2011-03-18 | US |
| (72) |
CLARK, Robin, US
HYND, George, GB
RAY, Nicholas, GB
SAJAD, Mohammad, GB
|
| (73) |
Corcept Therapeutics, Inc.,
149 Commonwealth Drive, Menlo Park CA 94025,
US
|
| (54) | PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS |
| PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR MODULATORS |